Thomas Needham is a Managing Director at Broadview Ventures and Longview Ventures with 30 years of experience in venture capital and life sciences. He serves on multiple boards and has held leadership roles at various companies.
At firms with a similar stage, sector and check size.




One email when Thomas's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckThomas Needham is a Managing Director at Broadview Ventures and Longview Ventures with 30 years of experience in venture capital and life sciences. He serves on multiple boards and has held leadership roles at various companies.
Broadview Ventures has not reported a check size. It invests at seed, series a.
A warm intro from a founder Broadview Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
Principal at Advent International; Managing Director at Synthesis Capital; Senior Vice President, Business Development at C4 Therapeutics; Chief Business Officer at Merrimack Pharmaceuticals; Managing Director at Longview Ventures; Chairman at Basking Biosciences; Chairman at Renovacor.
Last updated 2026-10-15. Is this you? Ask for a correction.